Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Our Stevenage facility offers dedicated cell therapy clinical trial support services and is a key collaborator in the Cell & Gene Therapy Catapult (CGT) "Manufacturing Operation Forum."
This 80,000 sq. ft. cell therapy manufacturing facility is projected to produce over 150,000 doses of cell therapy by 2023.
Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.